Clinical features and outcome of patients ...
Document type :
Article dans une revue scientifique
PMID :
Permalink :
Title :
Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study.
Author(s) :
Vuillard, Constance [Auteur]
Pineton De Chambrun, Marc [Auteur]
De Prost, Nicolas [Auteur]
Guerin, Claude [Auteur]
Schmidt, Matthieu [Auteur]
Dargent, Auguste [Auteur]
Quenot, Jean-Pierre [Auteur]
Preau, Sebastien [Auteur]
Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement (RID-AGE) - U1167
Lille Inflammation Research International Center (LIRIC) - U995
Ledoux, Geoffrey [Auteur]
Neuville, Mathilde [Auteur]
Voiriot, Guillaume [Auteur]
Fartoukh, Muriel [Auteur]
Coudroy, Remi [Auteur]
Dumas, Guillaume [Auteur]
Maury, Eric [Auteur]
Terzi, Nicolas [Auteur]
Tandjaoui-Lambiotte, Yacine [Auteur]
Schneider, Francis [Auteur]
Grall, Maximilien [Auteur]
Guerot, Emmanuel [Auteur]
Larcher, Romaric [Auteur]
Ricome, Sylvie [Auteur]
Le Mao, Raphael [Auteur]
Colin, Gwenhael [Auteur]
Guitton, Christophe [Auteur]
Zafrani, Lara [Auteur]
Morawiec, Elise [Auteur]
Dubert, Marie [Auteur]
Pajot, Olivier [Auteur]
Mentec, Herve [Auteur]
Plantefeve, Gaetan [Auteur]
Contou, Damien [Auteur]
Pineton De Chambrun, Marc [Auteur]
De Prost, Nicolas [Auteur]
Guerin, Claude [Auteur]
Schmidt, Matthieu [Auteur]
Dargent, Auguste [Auteur]
Quenot, Jean-Pierre [Auteur]
Preau, Sebastien [Auteur]
Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement (RID-AGE) - U1167
Lille Inflammation Research International Center (LIRIC) - U995
Ledoux, Geoffrey [Auteur]
Neuville, Mathilde [Auteur]
Voiriot, Guillaume [Auteur]
Fartoukh, Muriel [Auteur]
Coudroy, Remi [Auteur]
Dumas, Guillaume [Auteur]
Maury, Eric [Auteur]
Terzi, Nicolas [Auteur]
Tandjaoui-Lambiotte, Yacine [Auteur]
Schneider, Francis [Auteur]
Grall, Maximilien [Auteur]
Guerot, Emmanuel [Auteur]
Larcher, Romaric [Auteur]
Ricome, Sylvie [Auteur]
Le Mao, Raphael [Auteur]
Colin, Gwenhael [Auteur]
Guitton, Christophe [Auteur]
Zafrani, Lara [Auteur]
Morawiec, Elise [Auteur]
Dubert, Marie [Auteur]
Pajot, Olivier [Auteur]
Mentec, Herve [Auteur]
Plantefeve, Gaetan [Auteur]
Contou, Damien [Auteur]
Journal title :
Annals of Intensive Care
Abbreviated title :
Ann. Intensive Care
Volume number :
8
Pages :
87
Publication date :
2018-09-11
Keyword(s) :
Diagnosis
Inflammatory myositis
Interstitial lung disease
ARDS
Acute respiratory failure
Inflammatory myositis
Interstitial lung disease
ARDS
Acute respiratory failure
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Background
Anti-synthetase (AS) and dermato-pulmonary associated with anti-MDA-5 antibodies (aMDA-5) syndromes are near one of the other autoimmune inflammatory myopathies potentially responsible for severe acute interstitial ...
Show more >Background Anti-synthetase (AS) and dermato-pulmonary associated with anti-MDA-5 antibodies (aMDA-5) syndromes are near one of the other autoimmune inflammatory myopathies potentially responsible for severe acute interstitial lung disease. We undertook a 13-year retrospective multicenter study in 35 French ICUs in order to describe the clinical presentation and the outcome of patients admitted to the ICU for acute respiratory failure (ARF) revealing AS or aMDA-5 syndromes. Results From 2005 to 2017, 47 patients (23 males; median age 60 [1st–3rd quartiles 52–69] years, no comorbidity 85%) were admitted to the ICU for ARF revealing AS (n = 28, 60%) or aMDA-5 (n = 19, 40%) syndromes. Muscular, articular and cutaneous manifestations occurred in 11 patients (23%), 14 (30%) and 20 (43%) patients, respectively. Seventeen of them (36%) had no extra-pulmonary manifestations. C-reactive protein was increased (139 [40–208] mg/L), whereas procalcitonine was not (0.30 [0.12–0.56] ng/mL). Proportion of patients with creatine kinase ≥ 2N was 20% (n = 9/47). Forty-two patients (89%) had ARDS, which was severe in 86%, with a rate of 17% (n = 8/47) of extra-corporeal membrane oxygenation requirement. Proportion of patients who received corticosteroids, cyclophosphamide, rituximab, intravenous immunoglobulins and plasma exchange were 100%, 72%, 15%, 21% and 17%, respectively. ICU and hospital mortality rates were 45% (n = 21/47) and 51% (n = 24/47), respectively. Patients with aMDA-5 dermato-pulmonary syndrome had a higher hospital mortality than those with AS syndrome (n = 16/19, 84% vs. n = 8/28, 29%; p = 0.001). Conclusions Intensivists should consider inflammatory myopathies as a cause of ARF of unknown origin. Extra-pulmonary manifestations are commonly lacking. Mortality is high, especially in aMDA-5 dermato-pulmonary syndrome.Show less >
Show more >Background Anti-synthetase (AS) and dermato-pulmonary associated with anti-MDA-5 antibodies (aMDA-5) syndromes are near one of the other autoimmune inflammatory myopathies potentially responsible for severe acute interstitial lung disease. We undertook a 13-year retrospective multicenter study in 35 French ICUs in order to describe the clinical presentation and the outcome of patients admitted to the ICU for acute respiratory failure (ARF) revealing AS or aMDA-5 syndromes. Results From 2005 to 2017, 47 patients (23 males; median age 60 [1st–3rd quartiles 52–69] years, no comorbidity 85%) were admitted to the ICU for ARF revealing AS (n = 28, 60%) or aMDA-5 (n = 19, 40%) syndromes. Muscular, articular and cutaneous manifestations occurred in 11 patients (23%), 14 (30%) and 20 (43%) patients, respectively. Seventeen of them (36%) had no extra-pulmonary manifestations. C-reactive protein was increased (139 [40–208] mg/L), whereas procalcitonine was not (0.30 [0.12–0.56] ng/mL). Proportion of patients with creatine kinase ≥ 2N was 20% (n = 9/47). Forty-two patients (89%) had ARDS, which was severe in 86%, with a rate of 17% (n = 8/47) of extra-corporeal membrane oxygenation requirement. Proportion of patients who received corticosteroids, cyclophosphamide, rituximab, intravenous immunoglobulins and plasma exchange were 100%, 72%, 15%, 21% and 17%, respectively. ICU and hospital mortality rates were 45% (n = 21/47) and 51% (n = 24/47), respectively. Patients with aMDA-5 dermato-pulmonary syndrome had a higher hospital mortality than those with AS syndrome (n = 16/19, 84% vs. n = 8/28, 29%; p = 0.001). Conclusions Intensivists should consider inflammatory myopathies as a cause of ARF of unknown origin. Extra-pulmonary manifestations are commonly lacking. Mortality is high, especially in aMDA-5 dermato-pulmonary syndrome.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Inserm
Université de Lille
CHU Lille
Université de Lille
CHU Lille
Collections :
Research team(s) :
Glycation from inflammation to aging
Submission date :
2019-03-01T14:34:32Z
2024-03-06T14:11:13Z
2024-03-06T14:11:13Z
Files
- document
- Open access
- Access the document